{"id":"https://openalex.org/W4362593493","doi":"https://doi.org/10.1158/1538-7445.am2023-4290","title":"Abstract 4290: ReCorDE: A novel computational framework to discover potential combinations of anti-cancer drugs","display_name":"Abstract 4290: ReCorDE: A novel computational framework to discover potential combinations of anti-cancer drugs","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362593493","doi":"https://doi.org/10.1158/1538-7445.am2023-4290"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-4290","doi":"https://doi.org/10.1158/1538-7445.am2023-4290","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-4290","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052743982","display_name":"Emily T. Ghose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily T. Ghose","raw_affiliation_strings":["1Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042922246","display_name":"August J. John","orcid":"https://orcid.org/0000-0003-4615-9474","observed_orcids":["https://orcid.org/0000-0003-4615-9474"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"August John","raw_affiliation_strings":["1Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068630513","display_name":"Huanyao Gao","orcid":"https://orcid.org/0000-0002-9441-9579","observed_orcids":["https://orcid.org/0000-0002-9441-9579"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huanyao Gao","raw_affiliation_strings":["2Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085014608","display_name":"Krishna R. Kalari","orcid":"https://orcid.org/0000-0001-8944-8378","observed_orcids":["https://orcid.org/0000-0001-8944-8378"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krishna R. Kalari","raw_affiliation_strings":["2Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069578729","display_name":"Liewei Wang","orcid":"https://orcid.org/0000-0003-3818-8531","observed_orcids":["https://orcid.org/0000-0003-3818-8531"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liewei Wang","raw_affiliation_strings":["2Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"4290","last_page":"4290"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10887","display_name":"Bioinformatics and Genomic Networks","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticancer-drug-combination","display_name":"anticancer drug combination","score":0.8360000252723694},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7850000262260437},{"id":"https://openalex.org/keywords/atc-classification","display_name":"ATC classification","score":0.5529999732971191},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.6150000095367432},{"id":"https://openalex.org/keywords/yk-4-279","display_name":"YK-4-279","score":0.984000027179718},{"id":"https://openalex.org/keywords/ews-fli1","display_name":"EWS-FLI1","score":0.7390000224113464},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.734000027179718},{"id":"https://openalex.org/keywords/plk1-inhibitors","display_name":"PLK1 inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/aurora-kinase-inhibitors","display_name":"Aurora kinase inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.5329999923706055},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.3240000009536743},{"id":"https://openalex.org/keywords/prism","display_name":"PRISM","score":0.7509999871253967},{"id":"https://openalex.org/keywords/auc","display_name":"AUC","score":0.5979999899864197},{"id":"https://openalex.org/keywords/hypergeometric-test","display_name":"hypergeometric test","score":0.5649999976158142}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6794552206993103},{"id":"https://openalex.org/C184898388","wikidata":"https://www.wikidata.org/wiki/Q1435712","display_name":"Pairwise comparison","level":2,"score":0.6362544298171997},{"id":"https://openalex.org/C117220453","wikidata":"https://www.wikidata.org/wiki/Q5172842","display_name":"Correlation","level":2,"score":0.5408236980438232},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.5369659662246704},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5360356569290161},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46669700741767883},{"id":"https://openalex.org/C3020340455","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Cancer drugs","level":3,"score":0.44862231612205505},{"id":"https://openalex.org/C159744936","wikidata":"https://www.wikidata.org/wiki/Q1126730","display_name":"Spearman's rank correlation coefficient","level":2,"score":0.416411429643631},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.41632384061813354},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.378704309463501},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.2833334803581238},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2562370300292969},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.23811793327331543},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2236216962337494},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.14204096794128418},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-4290","doi":"https://doi.org/10.1158/1538-7445.am2023-4290","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-4290","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399247282","https://openalex.org/W2146416540","https://openalex.org/W2081321695","https://openalex.org/W2982291409","https://openalex.org/W2793608852","https://openalex.org/W3086367811","https://openalex.org/W2903093748","https://openalex.org/W2551072359","https://openalex.org/W4405131171","https://openalex.org/W3024785185"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Cancer":[2,457,476],"is":[3],"usually":[4],"treated":[5],"with":[6,18,68,78,231],"a":[7,13,19,60,104,143,162,232,247,255,350,404],"combination":[8,21,141,168,186,195,292,312],"of":[9,25,38,47,66,82,103,172,183,199,235,258,273,274,282,358,369,403,408,446,452],"drugs":[10,77,86,148,370],"rather":[11],"than":[12,128],"single":[14],"agent.":[15],"Treating":[16],"cancer":[17,27,380],"drug":[20,57,73,140,144,174,213,384,394],"decreases":[22],"the":[23,26,43,170,188,193,197,228,251,269,295,305,310,363,453],"likelihood":[24],"acquiring":[28],"resistance":[29],"to":[30,151,192,216,243,309,382,442],"therapy.":[31],"It":[32],"also":[33],"allows":[34],"for":[35,76,165,181,202,280,456],"lower":[36],"dosages":[37],"individual":[39],"drugs,":[40],"which":[41,70],"reduces":[42],"occurrence":[44],"and":[45,90,106,261,340,396,465],"severity":[46],"side":[48],"effects.":[49],"Using":[50],"public":[51],"datasets,":[52],"we":[53,113,179],"investigated":[54],"potential":[55,393,444],"anti-cancer":[56,447],"combinations":[58,175,201,214,284,361,368,395,445],"using":[59,95,118,161,227,250],"novel":[61,439],"framework,":[62,388],"ReCorDE":[63,101],"(Recurrent":[64],"Correlation":[65],"Drugs":[67],"Enrichment),":[69],"identifies":[71],"correlated":[72,415],"response":[74],"patterns":[75],"different":[79],"primary":[80,406],"mechanisms":[81,407],"action.":[83],"Methods:":[84],"250":[85],"from":[87,371,418],"CTRPv2,":[88],"GDSCv2,":[89],"PRISM":[91],"datasets":[92,130],"were":[93,135,149,302],"examined":[94],"normalized":[96],"logIC50":[97],"or":[98],"AUC":[99,252],"measurements.":[100],"consists":[102],"correlation":[105,256],"an":[107,263],"enrichment":[108,182,224,293,357],"step.":[109],"For":[110],"each":[111,139,166],"dataset,":[112],"constructed":[114],"pairwise":[115,205],"drug-drug":[116,206,416],"relationships":[117],"Spearman\u2019s":[119],"correlation.":[120],"Combinations":[121],"significant":[122,173,245],"(p":[123],"<":[124,287],"0.05)":[125],"in":[126,169,187,304,362,378],"less":[127],"two":[129],"after":[131,314],"Benjamini-Hochberg":[132],"(BH)":[133],"correction":[134],"pruned.":[136],"To":[137],"turn":[138],"into":[142],"class":[145,167,185,194,200,219,300,311,354,360],"combination,":[146],"all":[147,203],"mapped":[150,215],"their":[152],"corresponding":[153],"fourth-level":[154],"Anatomical":[155],"Therapeutic":[156],"Chemical":[157],"(ATC)":[158],"codes.":[159],"Then,":[160],"hypergeometric":[163],"test,":[164],"subset":[171],"(the":[176],"\u201cinside\u201d":[177],"set),":[178],"tested":[180],"that":[184,367,391],"inside":[189,306,364],"set":[190,297,307,365],"compared":[191,308,381],"universe,":[196],"distribution":[198],"unique":[204,209],"associations":[207],"(250":[208],"drugs;":[210],"31,125":[211],"distinct":[212,218],"1596":[217],"combinations).":[220],"Multiple":[221],"testing":[222],"during":[223],"was":[225],"corrected":[226],"BH":[229,315],"method":[230],"significance":[233],"cutoff":[234],"p<":[236],"0.05.":[237],"Results:":[238],"We":[239],"found":[240],"2764":[241],"pairs":[242,301,417],"be":[244,375,411],"at":[246],"=":[248,320,324,336,347],"0.05":[249],"measure.":[253],"With":[254],"coefficient":[257],"0.77,":[259],"vincristine":[260],"YK-4-279,":[262],"EWS-FLI1/RNA":[264],"Helicase":[265],"A":[266,438],"inhibitor,":[267],"had":[268,285],"lowest":[270],"computed":[271],"p-value":[272],"1.39":[275],"\u00d7":[276,289,326,338],"10\u2212120":[277],"Adjusted":[278],"p-values":[279,286],">15%":[281],"these":[283,359,372],"5":[288],"10\u22126.":[290],"Class":[291],"on":[294],"same":[296],"showed":[298],"132":[299],"enriched":[303,353],"universe":[313],"correction.":[316],"Taxanes/Plk1":[317],"inhibitors":[318,343],"(OR":[319],"69.5,":[321],"adjusted":[322,334,345],"p":[323,335,346],"5.6":[325],"10\u221211);":[327,339],"Aurora":[328],"Kinase":[329],"inhibitors/histone":[330],"modifying":[331],"agents":[332],"(OR=9.2,":[333],"6.13":[337],"pyrimidine":[341],"analogues/CDK":[342],"(OR=3.43,":[344],"0.02)":[348],"are":[349],"few":[351],"notable":[352],"combinations.":[355,385],"The":[356],"suggests":[366],"classes":[373],"may":[374],"particularly":[376],"effective":[377],"treating":[379],"other":[383],"Conclusions:":[386],"Our":[387],"ReCorDE,":[389],"demonstrates":[390],"finding":[392],"characterizing":[397],"novel,":[398],"frequently":[399],"perturbed":[400],"pathways":[401],"outside":[402],"drug's":[405],"action":[409],"can":[410],"accomplished":[412],"by":[413],"identifying":[414],"large,":[419],"publicly":[420],"accessible":[421],"databases.":[422],"Citation":[423],"Format:":[424],"Emily":[425],"T.":[426],"Ghose,":[427],"August":[428],"John,":[429],"Huanyao":[430],"Gao,":[431],"Krishna":[432],"R.":[433],"Kalari,":[434],"Liewei":[435],"Wang.":[436],"ReCorDE:":[437],"computational":[440],"framework":[441],"discover":[443],"drugs.":[448],"[abstract].":[449],"In:":[450],"Proceedings":[451],"American":[454],"Association":[455],"Research":[458],"Annual":[459],"Meeting":[460],"2023;":[461],"Part":[462],"1":[463],"(Regular":[464],"Invited":[466],"Abstracts);":[467],"2023":[468],"Apr":[469],"14-19;":[470],"Orlando,":[471],"FL.":[472],"Philadelphia":[473],"(PA):":[474],"AACR;":[475],"Res":[477],"2023;83(7_Suppl):Abstract":[478],"nr":[479],"4290.":[480]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-04-06T00:00:00"}